Yimin Shi

机构：Chinese University of Hong Kong, University of California, San Francisco, Xiamen University, Fudan University, Prince of Wales Hospital, Zhongshan Hospital of Xiamen University, Xiamen Medical College · ORCID：0000-0002-9779-5967

发表论文 75 篇 · 总被引 1718 次 · h-index 22

代表论文

• Astragaloside IV inhibits glucose-induced epithelial-mesenchymal transition of podocytes through autophagy enhancement via the SIRT–NF-κB p65 axis (2019 · Scientific Reports · 被引 111)
• Emodin mitigates podocytes apoptosis induced by endoplasmic reticulum stress through the inhibition of the PERK pathway in diabetic nephropathy (2018 · Drug Design Development and Therapy · 被引 86)
• Astragaloside IV improves renal function and fibrosis via inhibition of miR-21-induced podocyte dedifferentiation and mesangial cell activation in diabetic mice (2018 · Drug Design Development and Therapy · 被引 73)
• Astragaloside IV Attenuates High-Glucose-Induced Impairment in Diabetic Nephropathy by Increasing Klotho Expression via the NF-κB/NLRP3 Axis (2023 · Journal of Diabetes Research · 被引 33)
• Ginsenoside Rg1 Alleviates Podocyte EMT Passage by Regulating AKT/GSK3 β/β‐Catenin Pathway by Restoring Autophagic Activity (2020 · Evidence-based Complementary and Alternative Medicine · 被引 32)
• Ginsenoside Rg1 Alleviates Podocyte Injury Induced by Hyperlipidemia via Targeting the mTOR/NF‐κB/NLRP3 Axis (2020 · Evidence-based Complementary and Alternative Medicine · 被引 29)